These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M Kapusta K; Kar S; Collins JT; Franklin LM; Kolodziejczyk W; Leszczynski J; Hill GA J Biomol Struct Dyn; 2021 Oct; 39(17):6810-6827. PubMed ID: 32795148 [TBL] [Abstract][Full Text] [Related]
7. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956 [TBL] [Abstract][Full Text] [Related]
8. An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration. El-Saghier AM; Enaili SS; Abdou A; Kadry AM Mol Divers; 2024 Feb; 28(1):249-270. PubMed ID: 37946070 [TBL] [Abstract][Full Text] [Related]
9. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M Hicks EG; Kandel SE; Lampe JN Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739 [TBL] [Abstract][Full Text] [Related]
10. Molecular Docking, ADMET Analysis and Molecular Dynamics (MD) Simulation to Identify Synthetic Isoquinolines as Potential Inhibitors of SARS-CoV-2 M Dos Santos Correia PR; de Souza AHD; Chaparro AR; Tenorio Barajas AY; Porto RS Curr Comput Aided Drug Des; 2023; 19(5):391-404. PubMed ID: 36694326 [TBL] [Abstract][Full Text] [Related]
12. In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2. Khan S; Nasrullah ; Hussain A; Asif M; Sattar FA; Audhal FA; Qadir MI; Hamdard MH Medicine (Baltimore); 2023 Feb; 102(6):e31318. PubMed ID: 36820539 [TBL] [Abstract][Full Text] [Related]
13. In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M Das P; Majumder R; Mandal M; Basak P J Biomol Struct Dyn; 2021 Oct; 39(16):6265-6280. PubMed ID: 32705952 [TBL] [Abstract][Full Text] [Related]
14. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. C S; S DK; Ragunathan V; Tiwari P; A S; P BD J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178 [TBL] [Abstract][Full Text] [Related]
17. In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2. Chidambaram SK; Ali D; Alarifi S; Radhakrishnan S; Akbar I J Infect Public Health; 2020 Nov; 13(11):1671-1677. PubMed ID: 33008777 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies. Azeem M; Mustafa G; Mahrosh HS Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514 [TBL] [Abstract][Full Text] [Related]
19. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach. Kushwaha PP; Singh AK; Bansal T; Yadav A; Prajapati KS; Shuaib M; Kumar S Front Cell Infect Microbiol; 2021; 11():730288. PubMed ID: 34458164 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation. Abdelrheem DA; Ahmed SA; Abd El-Mageed HR; Mohamed HS; Rahman AA; Elsayed KNM; Ahmed SA J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(11):1373-1386. PubMed ID: 32998618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]